{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:37:48Z","timestamp":1793317068623,"version":"4.5.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.jaad.2016.10.048","type":"journal-article","created":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T12:52:07Z","timestamp":1497358327000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":399,"title":["New discoveries in the pathogenesis and classification of vitiligo"],"prefix":"10.1016","volume":"77","author":[{"given":"Michelle","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Ezzedine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iltefat","family":"Hamzavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit G.","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2016.10.048_bib1","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1067\/mjd.2001.114752","article-title":"Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo","volume":"44","author":"Scherschun","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1600-0781.2012.00648.x","article-title":"Evaluation of the effect of disease duration in generalized vitiligo on its clinical response to narrowband ultraviolet B phototherapy","volume":"28","author":"Hallaji","year":"2012","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.jaad.2016.10.048_bib3","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1468-3083.2007.02278.x","article-title":"Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy","volume":"21","author":"Brazzelli","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2016.10.048_bib4","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1365-4632.2011.05377.x","article-title":"A review of the worldwide prevalence of vitiligo in children\/adolescents and adults","volume":"51","author":"Kruger","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/gepi.1370020107","article-title":"Studies on vitiligo. I. Epidemiological profile in Calcutta, India","volume":"2","author":"Das","year":"1985","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.jaad.2016.10.048_bib6","first-page":"145","article-title":"Epidemiological study of vitiligo in Surat area, South Gujarat","volume":"61","author":"Mehta","year":"1973","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.jaad.2016.10.048_bib7","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0749.2003.00032.x","article-title":"Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families","volume":"16","author":"Alkhateeb","year":"2003","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.jaad.2016.10.048_bib8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/jid.1959.49","article-title":"Vitiligo","volume":"32","author":"Lerner","year":"1959","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/archderm.1977.01640010049006","article-title":"Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark","volume":"113","author":"Howitz","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib10","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaad.2015.07.039","article-title":"Vitiligo is not a cosmetic disease","volume":"73","author":"Ezzedine","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000084751","article-title":"Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage","volume":"210","author":"Ongenae","year":"2005","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2016.10.048_bib12","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1365-2133.2005.06456.x","article-title":"Effect\u00a0of\u00a0vitiligo on self-reported health-related quality of life","volume":"152","author":"Ongenae","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2133.2009.09091.x","article-title":"Willingness-to-pay and quality of life in patients with vitiligo","volume":"161","author":"Radtke","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaad.2009.03.022","article-title":"The burden of vitiligo: patient characteristics associated with quality of life","volume":"61","author":"Linthorst Homan","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2133.2003.05097_9.x","article-title":"Dermatology Life Quality Index score in vitiligo and its impact on the treatment outcome","volume":"148","author":"Parsad","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib16","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2230.2005.01779.x","article-title":"Vitiligo presentation in adults","volume":"30","author":"Mason","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib17","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1468-3083.2006.02106.x","article-title":"Stress in patients with alopecia areata\u00a0and vitiligo","volume":"21","author":"Manolache","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2016.10.048_bib18","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","article-title":"Revised classification\/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference","volume":"25","author":"Ezzedine","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jaad.2016.10.048_bib19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4103\/2229-5178.110636","article-title":"Coexistence of lip-tip vitiligo and disseminated discoid lupus erythematosus with hypothyroidism: need for careful therapeutic approach","volume":"4","author":"Sharma","year":"2013","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.jaad.2016.10.048_bib20","first-page":"92","article-title":"A clinical study of vitiligo","volume":"68","author":"Martis","year":"2002","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaad.2016.10.048_bib21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jaad.2010.11.061","article-title":"Vitiligo: a comprehensive overview. Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up","volume":"65","author":"Alikhan","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2133.2008.08815.x","article-title":"Chemical leucoderma: a clinico-aetiological study of 864 cases in the perspective of a developing country","volume":"160","author":"Ghosh","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.det.2016.11.006","article-title":"Chemical-induced vitiligo","volume":"35","author":"Harris","year":"2017","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2016.10.048_bib24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0190-9622(96)90718-5","article-title":"Segmental vitiligo: clinical findings in 208 patients","volume":"35","author":"Hann","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib25","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/jdv.12171","article-title":"Distribution patterns in generalized vitiligo","volume":"28","author":"Speeckaert","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2016.10.048_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1525-1470.1989.tb00265.x","article-title":"Survey of cutaneous lesions in Indian newborns","volume":"6","author":"Nanda","year":"1989","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib27","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jaad.2010.08.031","article-title":"Segmental vitiligo associated with generalized vitiligo (mixed vitiligo): a retrospective case series of 19 patients","volume":"65","author":"Ezzedine","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2133.2011.10709.x","article-title":"Halo naevi and leukotrichia are strong predictors of the passage to mixed vitiligo in a subgroup of segmental vitiligo","volume":"166","author":"Ezzedine","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1042\/CS20090603","article-title":"Vitiligo, reactive oxygen species and T-cells","volume":"120","author":"Glassman","year":"2011","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jaad.2016.10.048_bib30","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0190-9622(95)91282-7","article-title":"An epidemiologic case-control study in a population with vitiligo","volume":"33","author":"Barona","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib31","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archdermatol.2011.351","article-title":"Halo nevi association in nonsegmental vitiligo affects age at onset and depigmentation pattern","volume":"148","author":"Ezzedine","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib32","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/j.jaad.2013.01.012","article-title":"Vitiligo in 2 patients receiving vemurafenib for metastatic melanoma","volume":"69","author":"Alonso-Castro","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib33","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/cup.12735","article-title":"Cutaneous autoimmune effects in the setting of therapeutic immune checkpoint inhibition for metastatic melanoma","volume":"43","author":"Mochel","year":"2016","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2016.10.048_bib34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/jamadermatol.2015.2707","article-title":"Association of vitiligo with tumor response in patients with metastatic melanoma treated with pembrolizumab","volume":"152","author":"Hua","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib35","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1610-0387.2008.06755.x","article-title":"Vitiligo and melanoma-associated hypopigmentation (MAH): shared and discriminative features","volume":"6","author":"Hartmann","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2016.10.048_bib36","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jaad.2016.07.060","article-title":"Melanoma-associated leukoderma and vitiligo cannot be differentiated based on blinded assessment by experts in the field","volume":"75","author":"Lommerts","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib37","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1600-0749.2005.00244.x","article-title":"Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity?","volume":"18","author":"Garbelli","year":"2005","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.jaad.2016.10.048_bib38","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1365-2133.2012.11111.x","article-title":"Clinical significance of Koebner phenomenon in vitiligo","volume":"167","author":"van Geel","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib39","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0190-9622(00)90170-1","article-title":"Clinical and histopathologic characteristics of trichrome vitiligo","volume":"42","author":"Hann","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib40","first-page":"1219","article-title":"Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance","volume":"148","author":"Le Poole","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaad.2016.10.048_bib41","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jaad.2015.05.014","article-title":"Confetti-like depigmentation: a potential sign of rapidly progressing vitiligo","volume":"73","author":"Sosa","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0190-9622(99)70524-4","article-title":"Nevus depigmentosus: clinical features and histopathologic characteristics in 67 patients","volume":"40","author":"Lee","year":"1999","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib43","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/DAD.0b013e3181651511","article-title":"Histopathologic features in vitiligo","volume":"30","author":"Kim","year":"2008","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2016.10.048_bib44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0923-1811(94)90057-4","article-title":"Epidermal turnover time","volume":"8","author":"Iizuka","year":"1994","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2016.10.048_bib45","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa061592","article-title":"NALP1 in vitiligo-associated multiple autoimmune disease","volume":"356","author":"Jin","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2016.10.048_bib46","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jaad.2015.08.063","article-title":"Comorbid autoimmune diseases in patients with vitiligo: a cross-sectional study","volume":"74","author":"Gill","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib47","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/bjo.67.3.153","article-title":"Vitiligo and disorders of the retinal pigment epithelium","volume":"67","author":"Albert","year":"1983","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaad.2016.10.048_bib48","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0002-9394(83)90450-6","article-title":"New observations on vitiligo and ocular disease","volume":"96","author":"Wagoner","year":"1983","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jaad.2016.10.048_bib49","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/bjd.13276","article-title":"Most individuals with either segmental or non-segmental vitiligo display evidence of bilateral cochlear dysfunction","volume":"172","author":"Anbar","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib50","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.autrev.2014.01.023","article-title":"Diagnosis and classification of Vogt-Koyanagi-Harada disease","volume":"13","author":"Sakata","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaad.2016.10.048_bib51","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1159\/000304615","article-title":"Unilateral manifestations of tapeto-retinal degeneration, vitiligo, poliosis, grey hair and hypoacousia [in\u00a0French]","volume":"147","author":"Alezzandrini","year":"1964","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.jaad.2016.10.048_bib52","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/bjd.12166","article-title":"Autoimmune thyroid disease in vitiligo: multivariate analysis indicates intricate pathomechanisms","volume":"168","author":"Gey","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib53","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1038\/jid.2012.328","article-title":"Activation of the unfolded protein response in vitiligo: the missing link?","volume":"132","author":"Passeron","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib54","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1684\/ejd.2012.1884","article-title":"Oxidative stress and autoimmune skin disease","volume":"23","author":"Shah","year":"2013","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib55","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/exd.12103","article-title":"Vitiligo: interplay between oxidative stress and immune system","volume":"22","author":"Laddha","year":"2013","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib56","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1755-148X.2011.00878.x","article-title":"Monobenzone-induced depigmentation: from enzymatic blockade to autoimmunity","volume":"24","author":"van den Boorn","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jaad.2016.10.048_bib57","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/jid.2012.181","article-title":"Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8","volume":"132","author":"Toosi","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib58","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1755-148X.2011.00916.x","article-title":"HSP70i is a critical component of the immune response leading to vitiligo","volume":"25","author":"Mosenson","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jaad.2016.10.048_bib59","doi-asserted-by":"crossref","first-page":"174ra28","DOI":"10.1126\/scitranslmed.3005127","article-title":"Mutant HSP70 reverses autoimmune depigmentation in vitiligo","volume":"5","author":"Mosenson","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaad.2016.10.048_bib60","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-0625.2007.00666_1.x","article-title":"Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else?","volume":"17","author":"Schallreuter","year":"2008","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib61","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/jid.2011.321","article-title":"Six decades of vitiligo genetics: genome-wide studies provide insights into autoimmune pathogenesis","volume":"132","author":"Spritz","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib62","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.coi.2013.10.010","article-title":"Innate immune mechanisms in vitiligo: danger from within","volume":"25","author":"Richmond","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaad.2016.10.048_bib63","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.jidsp.5640189","article-title":"In\u00a0vivo and in\u00a0vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase","volume":"4","author":"Schallreuter","year":"1999","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jaad.2016.10.048_bib64","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/jid.2011.16","article-title":"Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy","volume":"131","author":"van den Boorn","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib65","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.0022-202X.2005.23653.x","article-title":"4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo","volume":"124","author":"Kroll","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib66","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/jid.2008.45","article-title":"HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo","volume":"128","author":"Denman","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib67","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/imr.12369","article-title":"Cellular stress and innate inflammation in organ-specific autoimmunity: lessons learned from vitiligo","volume":"269","author":"Harris","year":"2016","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaad.2016.10.048_bib68","doi-asserted-by":"crossref","first-page":"e51040","DOI":"10.1371\/journal.pone.0051040","article-title":"Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin","volume":"7","author":"Yu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2016.10.048_bib69","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/jid.2009.32","article-title":"Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients","volume":"129","author":"van den Boorn","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib70","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.188.6.1203","article-title":"High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo","volume":"188","author":"Ogg","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaad.2016.10.048_bib71","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jaad.2016.12.021","article-title":"Suction blistering the lesional skin of vitiligo patients reveal useful biomarkers of disease activity","volume":"76","author":"Strassner","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib72","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1523-1747.2001.01408.x","article-title":"Specific cytotoxic T\u00a0lymphocyte responses against Melan-A\/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex\/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo","volume":"117","author":"Palermo","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib73","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1046\/j.1523-1747.1998.00411.x","article-title":"Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy","volume":"111","author":"Okamoto","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib74","doi-asserted-by":"crossref","first-page":"223ra23","DOI":"10.1126\/scitranslmed.3007811","article-title":"CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo","volume":"6","author":"Rashighi","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaad.2016.10.048_bib75","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/jid.2011.463","article-title":"A mouse model of vitiligo with focused epidermal depigmentation requires IFN-gamma for autoreactive CD8(+) T-cell accumulation in the skin","volume":"132","author":"Harris","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib76","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.4049\/jimmunol.0902778","article-title":"Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice","volume":"184","author":"Gregg","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2016.10.048_bib77","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/pcmr.12219","article-title":"Type I interferon signature in the initiation of the immune response in vitiligo","volume":"27","author":"Bertolotti","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jaad.2016.10.048_bib78","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/bjd.14416","article-title":"Increased expression of CXCR3 and its ligands in vitiligo patients and CXCL10 as a potential clinical marker for vitiligo","volume":"174","author":"Wang","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib79","first-page":"343","article-title":"Interfering with the IFN-gamma\/CXCL10 pathway to develop new targeted treatments for vitiligo","volume":"3","author":"Rashighi","year":"2015","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jaad.2016.10.048_bib80","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2230.2010.03972.x","article-title":"Role of interleukin-17 in the pathogenesis of vitiligo","volume":"36","author":"Bassiouny","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib81","doi-asserted-by":"crossref","first-page":"e18907","DOI":"10.1371\/journal.pone.0018907","article-title":"Th17 cells and activated dendritic cells are increased in vitiligo lesions","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2016.10.048_bib82","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1684\/ejd.2013.2023","article-title":"Interleukin 17, interleukin 22 and FoxP3 expression in tissue\u00a0and serum of non-segmental vitiligo: a case- controlled study on eighty-four patients","volume":"23","author":"Elela","year":"2013","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib83","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/jdv.13759","article-title":"New-onset vitiligo and progression of pre-existing vitiligo during treatment with biological agents in chronic inflammatory diseases","volume":"31","author":"Mery-Bossard","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"suppl 1","key":"10.1016\/j.jaad.2016.10.048_bib84","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1007\/s10875-008-9176-5","article-title":"Primary immune deficiency disorders presenting as autoimmune diseases: IPEX and APECED","volume":"28","author":"Moraes-Vasconcelos","year":"2008","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaad.2016.10.048_bib85","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1126\/science.aaa1292","article-title":"Detection of self-reactive CD8(+) T cells with an anergic phenotype in healthy individuals","volume":"346","author":"Maeda","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jaad.2016.10.048_bib86","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1755-148X.2010.00688.x","article-title":"Reduced skin homing by functional Treg in vitiligo","volume":"23","author":"Klarquist","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jaad.2016.10.048_bib87","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00403-011-1154-8","article-title":"Levels of TGF-beta(1) in serum and culture supernatants of CD4(+)CD25 (+) T cells from patients with non-segmental vitiligo","volume":"303","author":"Tu","year":"2011","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2016.10.048_bib88","doi-asserted-by":"crossref","first-page":"e37513","DOI":"10.1371\/journal.pone.0037513","article-title":"Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo","volume":"7","author":"Lili","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2016.10.048_bib89","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1755-148X.2012.01019.x","article-title":"Systemic analyses of immunophenotypes of peripheral T cells in non-segmental vitiligo: implication of defective natural killer T cells","volume":"25","author":"Zhou","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jaad.2016.10.048_bib90","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/pcmr.12105","article-title":"Decreased regulatory T-cells and CD4(+) \/CD8(+) ratio correlate with disease onset and progression in patients with generalized vitiligo","volume":"26","author":"Dwivedi","year":"2013","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jaad.2016.10.048_bib91","series-title":"Vitiligo and Other Hypomelanoses of Hair and Skin","author":"Ortonne","year":"1983"},{"key":"10.1016\/j.jaad.2016.10.048_bib92","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2133.2011.10650.x","article-title":"New insights in segmental vitiligo: case report and review of theories","volume":"166","author":"van Geel","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib93","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/bjd.12013","article-title":"The distribution pattern of segmental vitiligo: clues for somatic mosaicism","volume":"468","author":"van Geel","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib94","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1755-148X.2010.00703.x","article-title":"First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi","volume":"23","author":"van Geel","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jaad.2016.10.048_bib95","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ydbio.2011.12.041","article-title":"Neural crest delamination and migration: from epithelium-to-mesenchyme transition to collective cell migration","volume":"366","author":"Theveneau","year":"2012","journal-title":"Dev Biol"},{"key":"10.1016\/j.jaad.2016.10.048_bib96","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.det.2016.11.013","article-title":"Genetics of vitiligo","volume":"35","author":"Spritz","year":"2017","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2016.10.048_bib97","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/ng.3680","article-title":"Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants","volume":"48","author":"Jin","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaad.2016.10.048_bib98","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/jama.1939.72800350003010a","article-title":"Occupational leukoderma","volume":"113","author":"Oliver","year":"1939","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2016.10.048_bib99","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1468-3083.2010.03876.x","article-title":"Depigmentation therapies for normal skin in vitiligo universalis","volume":"25","author":"AlGhamdi","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2016.10.048_bib100","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2133.1977.tb14275.x","article-title":"Monobenzylether of hydroquinone. A retrospective study of treatment of 18 vitiligo patients and a review of the literature","volume":"97","author":"Mosher","year":"1977","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib101","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/pcmr.12269","article-title":"Rhododendrol, a depigmentation-inducing phenolic compound, exerts melanocyte cytotoxicity via a tyrosinase-dependent mechanism","volume":"27","author":"Sasaki","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jaad.2016.10.048_bib102","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jdermsci.2015.02.001","article-title":"Biochemical, cytological, and immunological mechanisms of rhododendrol-induced leukoderma","volume":"77","author":"Tokura","year":"2015","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2016.10.048_bib103","first-page":"386","article-title":"Occupational depigmentation due to 4-tertiarybutyl catechol (TBC)","volume":"12","author":"Gellin","year":"1970","journal-title":"J Occup Med"},{"key":"10.1016\/j.jaad.2016.10.048_bib104","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1600-0536.1981.tb04598.x","article-title":"Occupational leukoderma and contact dermatitis from paratertiary-butylphenol","volume":"7","author":"Romaguera","year":"1981","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaad.2016.10.048_bib105","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/1346-8138.12744","article-title":"Guide for medical professionals (i.e., dermatologists) for the management of\u00a0Rhododenol-induced leukoderma","volume":"42","author":"Nishigori","year":"2015","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib106","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/pcmr.12402","article-title":"Use of permanent hair dyes and risk of vitiligo in women","volume":"28","author":"Wu","year":"2015","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jaad.2016.10.048_bib107","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1755-148X.2011.00922.x","article-title":"In\u00a0vivo vitiligo\u00a0induction and therapy model: double-blind, randomized clinical trial","volume":"25","author":"van Geel","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jaad.2016.10.048_bib108","first-page":"844","article-title":"Vitiligo-like hypopigmentation with\u00a0poliosis following treatment of superficial basal cell\u00a0carcinoma with imiquimod","volume":"34","author":"Jacob","year":"2008","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2016.10.048_bib109","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jaad.2004.10.861","article-title":"Vitiligo-like hypopigmentation associated with imiquimod treatment of genital warts","volume":"52","author":"Brown","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib110","doi-asserted-by":"crossref","first-page":"482","DOI":"10.5021\/ad.2012.24.4.482","article-title":"Induction of vitiligo-like hypopigmentation after imiquimod treatment of extramammary Paget's disease","volume":"24","author":"Kwon","year":"2012","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib111","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000320207","article-title":"Vitiligo at injection site of PEG-IFN-alpha 2a in two patients with chronic hepatitis C: case report and literature review","volume":"2","author":"Arya","year":"2010","journal-title":"Case Rep Dermatol"},{"key":"10.1016\/j.jaad.2016.10.048_bib112","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1084\/jem.20101102","article-title":"Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons","volume":"207","author":"Gregorio","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaad.2016.10.048_bib113","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/icb.2010.158","article-title":"CXCR3 ligands: redundant, collaborative and antagonistic functions","volume":"89","author":"Groom","year":"2011","journal-title":"Immunol Cell Biol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221631115X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221631115X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:40:59Z","timestamp":1759272059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096221631115X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":113,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S019096221631115X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2016.10.048","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727762522.793535278","asserted-by":"object"}]},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New discoveries in the pathogenesis and classification of vitiligo","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2016.10.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S0190-9622(17)31742-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}